Premarket Mover: G1 Therapeutics Inc (GTHX) Up 1.88%

Monday, March 04, 2024 09:06 AM | InvestorsObserver Analysts

Mentioned in this article

G1 Therapeutics Inc (GTHX) has gained Monday morning, with the stock increasing 1.88% in pre-market trading to 3.8. GTHX's short-term technical score of 70 indicates that the stock has traded more bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 86 out of 146 industries, GTHX ranks higher than 77% of stocks. G1 Therapeutics Inc has fallen 11.40% over the past month, closing at $4.40 on February 5. During this period of time, the stock fell as low as $2.10 and as high as $5.00. GTHX has an average analyst recommendation of Buy. The company has an average price target of $8.50.

GTHX has an Overall Score of 84. Find out what this means to you and get the rest of the rankings on GTHX!
G1 Therapeutics Inc has a Long-Term Technical rank of 87. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 13% of the market scoring higher. In the Biotechnology industry which is number 44 by this metric, GTHX ranks better than 44% of stocks.

Important Dates for Investors in GTHX:

-G1 Therapeutics Inc is set to release earnings on 2024-05-28. Over the last 12 months, the company has reported EPS of $-1.47. -We do not have a set dividend date for G1 Therapeutics Inc at this time. Click Here To Get The Full Report on G1 Therapeutics Inc (GTHX)

Share this article: